GSK (LSE:GSK) secured multi region regulatory approvals in China and the European Union for depemokimab, branded as Exdensur, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results